Categories: News

LifeMD to Participate in the Upcoming May Conferences

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) — LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that that management will participate in the following upcoming conferences:

H.C. Wainwright Conference

Date:  May 23–26, 2022
Format:  On-demand presentation; available for one-on-one meetings
Registration:  register here 

B. Riley Securities 22nd Annual Institutional Investor Conference

Date: Thursday, May 26, 2022
Time:  11:50 am ET / 8:50 am PT
Format:   Available for one-on-one meetings May 25-26
Registration: To request a meeting please contact: 1on1@brileyfin.com

Links to the live presentations will be available on the investor portion of the company’s website, which can be found at https://ir.lifemd.com/#/. A copy of the replay will be available for 90 days.

About LifeMD
LifeMD™ is a 50-state direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group, and nationwide mail-order pharmacy network, LifeMD™ is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to LifeMD.com.

Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.

Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.

Company Contact                                
LifeMD, Inc.        
Marc Benathen, CFO
Email Contact

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

Media Contact
Eric Herman
Kivvit
eherman@kivvit.com 

Staff

Recent Posts

Orlando Medical Waste Disposal Company Addresses Increase in Needlestick Injuries With Key Guide

There are approximately 385,000 needlestick and sharps-related injuries among healthcare workers each year in the…

2 hours ago

NCQA Announces Two New Members to Board of Directors

New health care leaders include Dr. J. Marc Overhage and Dr. Geoffrey Neimark WASHINGTON, D.C.,…

2 hours ago

Vivalink Recognized with 2024 Global Healthcare IT Solutions Award by Frost & Sullivan

Vivalink honored for enabling technology leadership with its innovative remote patient monitoring solutions CAMPBELL, Calif.,…

5 hours ago

UNC Health Wayne Includes MEDI+SIGN Digital Whiteboards in Their Mission to Enhance Patient Care

SMITHSBURG, Md., Jan. 9, 2025 /PRNewswire/ -- UNC Health Wayne, a leading healthcare institution committed…

5 hours ago

Transforming Contact Centers: How GTS Helps Businesses Deliver Exceptional Customer Experiences with AI and Innovation

ALTA LOMA, Calif., Jan. 9, 2025 /PRNewswire/ -- GTSCX.AI – What does transforming a contact…

5 hours ago

Annexus Health Rings In 2025 By Surpassing $6 Billion in Patient Financial Assistance Awards Secured

Driven by a network of more than 4,200 sites of care now using the AssistPoint®…

5 hours ago